HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tezosentan

structure in first source
Also Known As:
5-isopropyl-pyridine-2-sulfonic acid 6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(2-1H-tetrazol-5-yl--pyridin-4-yl)--pyrimidin-4-ylamide; RO 61-0612; RO 610612; Veletri
Networked: 88 relevant articles (13 outcomes, 29 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kobrin, Isaac: 10 articles (01/2011 - 10/2002)
2. Frey, Aline: 10 articles (01/2011 - 10/2002)
3. Rainisio, Maurizio: 7 articles (01/2011 - 05/2003)
4. Teerlink, John R: 6 articles (01/2011 - 07/2003)
5. O'Connor, Christopher M: 6 articles (11/2007 - 10/2002)
6. Dingemanse, Jasper: 5 articles (05/2012 - 04/2002)
7. Torre-Amione, Guillermo: 5 articles (11/2007 - 07/2003)
8. Kaluski, Edo: 4 articles (01/2011 - 01/2003)
9. Oldner, Anders: 4 articles (10/2009 - 05/2004)
10. Clozel, Martine: 4 articles (12/2008 - 01/2002)

Related Diseases

1. Heart Failure
2. Pulmonary Hypertension (Ayerza Syndrome)
3. Lung Injury
4. Dyspnea (Shortness of Breath)
5. Ischemia

Related Drugs and Biologics

1. Endothelin Receptors (Endothelin Receptor)
2. Endothelins (Endothelin)
3. Idiopathic pulmonary hypertension
4. Endothelin-1 (Endothelin 1)
5. alpha-naphthyl thiourea (ANTU)
6. tolvaptan
7. Vasopressins (Vasopressin)
8. simendan (Levosimendan)
9. Oleic Acid (Oleate)
10. Troponin I

Related Therapies and Procedures

1. Intravenous Injections
2. Intravenous Infusions
3. Laparotomy
4. Caloric Restriction
5. Stents